Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.504
-0.096 (-16.02%)
At close: Nov 22, 2024, 4:00 PM
0.520
+0.016 (3.20%)
After-hours: Nov 22, 2024, 7:59 PM EST
Lineage Cell Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 95 | 191 | 199 | 413 | 264 | 133 | |
Market Cap Growth | -17.21% | -4.09% | -51.84% | 56.44% | 98.01% | 19.78% | |
Enterprise Value | 64 | 151 | 134 | 349 | 228 | 101 | |
Last Close Price | 0.50 | 1.09 | 1.17 | 2.45 | 1.76 | 0.89 | |
PS Ratio | 10.63 | 21.32 | 13.53 | 95.13 | 144.57 | 37.93 | |
PB Ratio | 1.44 | 3.08 | 2.76 | 4.54 | 2.78 | 1.20 | |
P/TBV Ratio | 19.05 | 30.84 | 12.45 | 11.89 | 6.86 | 2.47 | |
P/FCF Ratio | - | - | 307.85 | - | - | - | |
P/OCF Ratio | - | - | 187.79 | - | - | - | |
EV/Sales Ratio | 7.32 | 16.88 | 9.11 | 80.50 | 124.70 | 28.82 | |
EV/FCF Ratio | - | - | 207.31 | - | - | - | |
Debt / Equity Ratio | 0.04 | 0.05 | 0.05 | 0.03 | 0.04 | 0.05 | |
Debt / FCF Ratio | - | - | 6.03 | - | - | - | |
Asset Turnover | 0.09 | 0.08 | 0.10 | 0.03 | 0.02 | 0.03 | |
Quick Ratio | 2.39 | 2.02 | 3.06 | 2.32 | 5.35 | 4.78 | |
Current Ratio | 2.48 | 2.14 | 3.16 | 2.37 | 5.66 | 8.86 | |
Return on Equity (ROE) | -30.50% | -32.07% | -32.37% | -46.52% | -20.05% | -11.62% | |
Return on Assets (ROA) | -11.84% | -11.80% | -9.44% | -21.78% | -14.16% | -18.59% | |
Return on Capital (ROIC) | -17.48% | -18.82% | -16.60% | -31.93% | -15.35% | -20.02% | |
Earnings Yield | -21.13% | -11.26% | -13.21% | -10.42% | -7.82% | -8.78% | |
FCF Yield | -24.23% | -15.33% | 0.32% | -5.79% | -7.51% | -24.29% | |
Buyback Yield / Dilution | -7.29% | -1.69% | -3.22% | -9.64% | -3.10% | -14.68% | |
Total Shareholder Return | -7.29% | -1.69% | -3.22% | -9.64% | -3.10% | -14.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.